Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-03-29, Stock:NVO, The news for the past five days is as follows:
2018-03-22: NEWS1: 30 Most Obese Countries In The World in 2018: Biggest Anti-Obesity Drug Markets.NEWS2: 30 Most Obese Countries In The World in 2018: Biggest Anti-Obesity Drug Markets.NEWS3: Drugmaker Novo Nordisk looks to former oil boss to energise M&A.
2018-03-23: NEWS1: These 12 Drugs Launching In 2018 Are Headed For Blockbuster Status.NEWS2: These 12 Drugs Launching In 2018 Are Headed For Blockbuster Status.NEWS3: Novo Nordisk: Ozempic Approved In Japan To Treat Adults With Type 2 Diabetes.NEWS4: Novo Nordisk: Ozempic Approved In Japan To Treat Adults With Type 2 Diabetes.
2018-03-26: NEWS1: Novo Nordisk : FDA Approves Update To US Prescribing Information For Tresiba.NEWS2: Novo Nordisk : FDA Approves Update To US Prescribing Information For Tresiba.
2018-03-27: nan
2018-03-28: NEWS1: Noteworthy ETF Outflows: VGK, RDS.B, SAP, NVO.NEWS2: Noteworthy ETF Outflows: VGK, RDS.B, SAP, NVO.NEWS3: Market Trends Toward New Normal in Novo Nordisk A/S, Brookfield Asset Management, Dun & Bradstreet, Goldcorp, NorthStar Asset Management Group, and IMAX — Emerging Consolidated Expectations, Analyst Ratings.

Answer: Rise